HSPGs possess a key role in tumor cell malignancy, and families of HSPGs, such as syndecans, glypicans, or perlecans, are often upregulated or overexpressed in cancer, associated with growth, proliferation, and a bad prognosis. Here, HSPG2 is linked to neoplasm.